Investment Type: Venture Capital
Mentions in press and media 11
| Date | Title | Description | Category | Author | Source |
| 15.12.2016 | Oncorus An... | Oncorus®, Inc., a new immuno-o... | - | - | citybizlis... |
| 20.05.2013 | eFFECTOR T... | eFFECTOR Therapeutics, a San D... | funding S... | - | finsmes.co... |
| 20.05.2013 | eFFECTOR T... | eFFECTOR Therapeutics Raises $... | Venture Ca... | - | fiercebiot... |
| 26.02.2013 | DecImmune ... | DecImmune Therapeutics, a Camb... | funding S... | - | finsmes.co... |
| 26.02.2013 | DecImmune ... | CAMBRIDGE, MA, DecImmune The... | - | - | vcnewsdail... |
| 21.08.2012 | Type 2 dia... | The biotechnology firm raised ... | - | - | medcitynew... |
| 15.11.2011 | Hyperglyce... | GLP-1 analogues that have been... | - | - | medcitynew... |
| 11.10.2011 | Cleave Bio... | Cleave Biosciences, a Burlinga... | funding S... | - | finsmes.co... |
| 07.01.2009 | Intradigm ... | Biotech firm Intradigm has tac... | - | - | venturebea... |
| - | Type 2 dia... | A biotechnology company develo... | - | - | medcitynew... |
Show more